Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas

Nano Letters

Volumn 16, Issue 5, 2016, Pages 3202-3209

  Holbrook, Robert J ^a   Rammohan, Nikhil ^a   Rotz, Matthew W ^a   Macrenaris, Keith W ^a   Preslar, Adam T ^a   Meade, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

gold nanoparticles; magnetic resonance imaging; Pancreas

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; FIBER OPTIC SENSORS; GOLD; GOLD COMPOUNDS; IMAGING TECHNIQUES; MAGNETISM; MEDICINE; METAL NANOPARTICLES; NANOMAGNETICS; NANOPARTICLES; RESONANCE; SYNTHESIS (CHEMICAL); TISSUE;

CONTRAST TO NOISE RATIO; GOLD NANOPARTICLES; HIGH MAGNETIC FIELDS; LONGITUDINAL RESPONSE; PANCREAS; PANCREATIC ADENOCARCINOMA; PARTICLE LOCALIZATIONS; SYNTHESIS AND CHARACTERIZATIONS;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; GADOLINIUM; GOLD; METAL NANOPARTICLE; NANOCONJUGATE; THIOL DERIVATIVE;

ANIMAL; C57BL MOUSE; CHEMISTRY; DIAGNOSTIC IMAGING; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PARTICLE SIZE; PROCEDURES; SURFACE PROPERTY; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; GOLD; HETEROGRAFTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METAL NANOPARTICLES; MICE, INBRED C57BL; NANOCONJUGATES; PANCREATIC NEOPLASMS; PARTICLE SIZE; SULFHYDRYL COMPOUNDS; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84974846049     PISSN: 15306984     EISSN: 15306992     Source Type: Journal    
DOI: 10.1021/acs.nanolett.6b00599     Document Type: Article

References (38)

1. Klein, A. P. Identifying people at a high risk of developing pancreatic cancer Nat. Rev. Cancer 2012, 13, 66-74 10.1038/nrc3420
2. Abbruzzese, J. The challenge of pancreatic cancer Int. J. Gastrointest. Cancer 2003, 33, 1-2 10.1385/IJGC:33:1:1
3. Hidalgo, M.; Cascinu, S.; Kleeff, J.; Labianca, R.; Löhr, J. M.; Neoptolemos, J.; Real, F. X.; Van Laethem, J.-L.; Heinemann, V. Addressing the challenges of pancreatic cancer: Future directions for improving outcomes Pancreatology 2015, 15, 8-18 10.1016/j.pan.2014.10.001
4. Dempsey, M. F.; Condon, B.; Hadley, D. M. MRI safety review Seminars in Ultrasound, CT and MRI 2002, 23, 392-401 10.1016/S0887-2171(02)90010-7
5. Shellock, F. G.; Spinazzi, A. MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis AJR, Am. J. Roentgenol. 2008, 191, 1129-1139 10.2214/AJR.08.1038.1
6. Willinek, W. A.; Schild, H. H. Clinical advantages of 3.0 T MRI over 1.5 T Eur. J. Radiol. 2008, 65, 2-14 10.1016/j.ejrad.2007.11.006
7. Harrison, V. S. R.; Carney, C. E.; MacRenaris, K. W.; Waters, E. A.; Meade, T. J. Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging J. Am. Chem. Soc. 2015, 137, 9108 10.1021/jacs.5b04509
8. Strauch, R. C.; Mastarone, D. J.; Sukerkar, P. A.; Song, Y.; Ipsaro, J. J.; Meade, T. J. Reporter Protein-Targeted Probes for Magnetic Resonance Imaging J. Am. Chem. Soc. 2011, 133, 16346-16349 10.1021/ja206134b
9. Sukerkar, P. A.; MacRenaris, K. W.; Meade, T. J.; Burdette, J. E. A Steroid-Conjugated Magnetic Resonance Probe Enhances Contrast in Progesterone Receptor Expressing Organs and Tumors in Vivo Mol. Pharmaceutics 2011, 8, 1390-1400 10.1021/mp200219e
10. Hung, A. H.; Holbrook, R. J.; Rotz, M. W.; Glasscock, C. J.; Mansukhani, N. D.; MacRenaris, K. W.; Manus, L. M.; Duch, M. C.; Dam, K. T.; Hersam, M. C.; Meade, T. J. Graphene Oxide Enhances Cellular Delivery of Hydrophilic Small Molecules by Co-incubation ACS Nano 2014, 8, 10168-10177 10.1021/nn502986e
11. Jensen, S. A.; Day, E. S.; Ko, C. H.; Hurley, L. A.; Luciano, J. P.; Kouri, F. M.; Merkel, T. J.; Luthi, A. J.; Patel, P. C.; Cutler, J. I.; Daniel, W. L.; Scott, A. W.; Rotz, M. W.; Meade, T. J.; Giljohann, D. A.; Mirkin, C. A.; Stegh, A. H. Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma Sci. Transl. Med. 2013, 5, 209ra152 10.1126/scitranslmed.3006839
12. Rotz, M. W.; Culver, K. S. B.; Parigi, G.; MacRenaris, K. W.; Luchinat, C.; Odom, T. W.; Meade, T. J. High Relaxivity Gd(III)-DNA Gold Nanostars: Investigation of Shape Effects on Proton Relaxation ACS Nano 2015, 9, 3385-3396 10.1021/nn5070953
13. Song, Y.; Xu, X.; MacRenaris, K. W.; Zhang, X.-Q.; Mirkin, C. A.; Meade, T. J. Multimodal Gadolinium-Enriched DNA-Gold Nanoparticle Conjugates for Cellular Imaging Angew. Chem., Int. Ed. 2009, 48, 9143-9147 10.1002/anie.200904666
14. Alric, C.; Taleb, J.; Duc, G. L.; Mandon, C.; Billotey, C.; Meur-Herland, A. L.; Brochard, T.; Vocanson, F.; Janier, M.; Perriat, P.; Roux, S.; Tillement, O. Gadolinium Chelate Coated Gold Nanoparticles As Contrast Agents for Both X-ray Computed Tomography and Magnetic Resonance Imaging J. Am. Chem. Soc. 2008, 130, 5908-5915 10.1021/ja078176p
15. Park, J.-A.; Reddy, P. A. N.; Kim, H.-K.; Kim, I.-S.; Kim, G.-C.; Chang, Y.; Kim, T.-J. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent Bioorg. Med. Chem. Lett. 2008, 18, 6135-6137 10.1016/j.bmcl.2008.10.017
16. Sung, S.; Holmes, H.; Wainwright, L.; Toscani, A.; Stasiuk, G. J.; White, A. J. P.; Bell, J. D.; Wilton-Ely, J. D. E. T. Multimetallic Complexes and Functionalized Gold Nanoparticles Based on a Combination of d- and f-Elements Inorg. Chem. 2014, 53, 1989-2005 10.1021/ic401936w
17. Irure, A.; Marradi, M.; Arnaiz, B.; Genicio, N.; Padro, D.; Penades, S. Sugar/gadolinium-loaded gold nanoparticles for labelling and imaging cells by magnetic resonance imaging Biomater. Sci. 2013, 1, 658-668 10.1039/c3bm60032g
18. Ferreira, M. F.; Goncalves, J.; Mousavi, B.; Prata, M. I. M.; Rodrigues, S. P. J.; Calle, D.; Lopez-Larrubia, P.; Cerdan, S.; Rodrigues, T. B.; Ferreira, P. M.; Helm, L.; Martins, J. A.; Geraldes, C. F. G. C. Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity Dalton Transactions 2015, 44, 4016-4031 10.1039/C4DT03210A
19. Lewis, D. J.; Pikramenou, Z. Lanthanide-coated gold nanoparticles for biomedical applications Coord. Chem. Rev. 2014, 273-274, 213-225 10.1016/j.ccr.2014.03.019
20. Zeng, Y.; Zhang, D.; Wu, M.; Liu, Y.; Zhang, X.; Li, L.; Li, Z.; Han, X.; Wei, X.; Liu, X. Lipid-AuNPs@PDA Nanohybrid for MRI/CT Imaging and Photothermal Therapy of Hepatocellular Carcinoma ACS Appl. Mater. Interfaces 2014, 6, 14266-14277 10.1021/am503583s
21. Arvizo, R. R.; Miranda, O. R.; Moyano, D. F.; Walden, C. A.; Giri, K.; Bhattacharya, R.; Robertson, J. D.; Rotello, V. M.; Reid, J. M.; Mukherjee, P. Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles PLoS One 2011, 6, e24374 10.1371/journal.pone.0024374
22. Hung, A. H.; Duch, M. C.; Parigi, G.; Rotz, M. W.; Manus, L. M.; Mastarone, D. J.; Dam, K. T.; Gits, C. C.; MacRenaris, K. W.; Luchinat, C.; Hersam, M. C.; Meade, T. J. Mechanisms of Gadographene-Mediated Proton Spin Relaxation J. Phys. Chem. C 2013, 117, 16263-16273 10.1021/jp406909b
23. Burda, C.; Chen, X.; Narayanan, R.; El-Sayed, M. A. Chemistry and Properties of Nanocrystals of Different Shapes Chem. Rev. 2005, 105, 1025-1102 10.1021/cr030063a
24. Grimm, J.; Potthast, A.; Wunder, A.; Moore, A. Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer Int. J. Cancer 2003, 106, 806-811 10.1002/ijc.11281
25. Lasagna-Reeves, C.; Gonzalez-Romero, D.; Barria, M. A.; Olmedo, I.; Clos, A.; Sadagopa Ramanujam, V. M.; Urayama, A.; Vergara, L.; Kogan, M. J.; Soto, C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice Biochem. Biophys. Res. Commun. 2010, 393, 649-655 10.1016/j.bbrc.2010.02.046
26. Sadauskas, E.; Wallin, H.; Stoltenberg, M.; Vogel, U.; Doering, P.; Larsen, A.; Danscher, G. Kupffer cells are central in the removal of nanoparticles from the organism Part. Fibre Toxicol. 2007, 4, 10 10.1186/1743-8977-4-10
27. Koh, D.-M.; Collins, D. J. Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology AJR, Am. J. Roentgenol. 2007, 188, 1622-1635 10.2214/AJR.06.1403
28. Patra, C. R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer Adv. Drug Delivery Rev. 2010, 62, 346-61 10.1016/j.addr.2009.11.007
29. Patra, C. R.; Bhattacharya, R.; Wang, E.; Katarya, A.; Lau, J. S.; Dutta, S.; Muders, M.; Wang, S.; Buhrow, S. A.; Safgren, S. L.; Yaszemski, M. J.; Reid, J. M.; Ames, M. M.; Mukherjee, P.; Mukhopadhyay, D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent Cancer Res. 2008, 68, 1970-8 10.1158/0008-5472.CAN-07-6102
30. Bellingan, G. J.; Xu, P.; Cooksley, H.; Cauldwell, H.; Shock, A.; Bottoms, S.; Haslett, C.; Mutsaers, S. E.; Laurent, G. J. Adhesion Molecule-dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal Inflammation J. Exp. Med. 2002, 196, 1515-1521 10.1084/jem.20011794
31. Miller, F. H.; Rini, N. J.; Keppke, A. L. MRI of adenocarcinoma of the pancreas AJR, Am. J. Roentgenol. 2006, 187, W365-74 10.2214/AJR.05.0875
32. Tummala, P.; Junaidi, O.; Agarwal, B. Imaging of pancreatic cancer: An overview J. Gastrointest. Oncol. 2011, 2, 168-74
33. Lee, G. Y.; Qian, W. P.; Wang, L.; Wang, Y. A.; Staley, C. A.; Satpathy, M.; Nie, S.; Mao, H.; Yang, L. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer ACS Nano 2013, 7, 2078-89 10.1021/nn3043463
34. Torres, G. M.; Erquiaga, E.; Ros, P. R.; Burton, S. S.; Barreda, R.; Langmo, L. S.; Kennedy, S. J. Preliminary results of MR imaging with superparamagnetic iron oxide in pancreatic and retroperitoneal disorders Radiographics: a review publication of the Radiological Society of North America, Inc 1991, 11, 785-91 discussion 792-3 10.1148/radiographics.11.5.1947314
35. Botsikas, D.; Terraz, S.; Vinet, L.; Lamprianou, S.; Becker, C. D.; Bosco, D.; Meda, P.; Montet, X. Pancreatic magnetic resonance imaging after manganese injection distinguishes type 2 diabetic and normoglycemic patients Islets 2012, 4, 243-8 10.4161/isl.20857
36. Diehl, S. J.; Lehmann, K. J.; Gaa, J.; McGill, S.; Hoffmann, V.; Georgi, M. MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate Invest. Radiol. 1999, 34, 589-95 10.1097/00004424-199909000-00007
37. Schima, W. MRI of the pancreas: tumours and tumour-simulating processes Cancer Imaging 2006, 6, 199-203 10.1102/1470-7330.2006.0035
38. Birchard, K. R.; Semelka, R. C.; Hyslop, W. B.; Brown, A.; Armao, D.; Firat, Z.; Vaidean, G. Suspected pancreatic cancer: evaluation by dynamic gadolinium-enhanced 3D gradient-echo MRI AJR, Am. J. Roentgenol. 2005, 185, 700-3 10.2214/ajr.185.3.01850700